• Profile
Close

Significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the US: A cross-sectional analysis of 2011-2014 National Health and Nutrition Examination Survey

Alimentary Pharmacology and Therapeutics Sep 20, 2017

Wong RJ, et al. - This cross-sectional analysis intended to assess prevalence and predictors of hepatic fibrosis among US adults with nonalcoholic fatty liver disease (NAFLD). Among US adults, NAFLD represented as a major healthcare burden with as many as 5 million adults estimated to have NAFLD with ≥F3 fibrosis. Factors independently correlated with higher risk of fibrosis were age and the components of the metabolic syndrome.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay